scholarly journals Renal artery aneurysm misdiagnosed as renal cell carcinoma

2020 ◽  
Vol 7 (4) ◽  
pp. 1296
Author(s):  
Shashi . ◽  
Rajdeep Singh ◽  
Manu Vats

Renal tumors are best diagnosed by contrast-enhanced computed tomography (CECT) abdomen along with history and physical examination. In case of suspicious lesions in respect to location like lesion arising from the bifurcation of renal artery and close to major vessels with all features suggesting of tumor with absent contrast enhancement and absent color flow on Doppler study should be further investigated keeping other possibility of Renal artery aneurysm with thrombus mimicking as renal tumor. CT angiography should be done in every case of suspicious lesion because this will change the further management protocol from Nephrectomy in case of renal tumor to kidney preserving minimally invasive procedure for renal artery aneurysm. Like in this case diagnosis of Renal cell carcinoma was made on the basis of CECT abdomen findings and managed further as per the management protocol for renal tumor but intraoperatively found renal artery aneurysm. On conclusion every suspicious lesion of kidney should be further investigated for renal artery aneurysm so that kidney preserving procedure could be planned preoperatively.

2011 ◽  
Vol 18 (7) ◽  
pp. 533-535 ◽  
Author(s):  
Yoichi Osako ◽  
Shuichi Tatarano ◽  
Kenryu Nishiyama ◽  
Yasutoshi Yamada ◽  
Takaaki Yamagata ◽  
...  

2002 ◽  
Vol 16 (3) ◽  
pp. 353-357 ◽  
Author(s):  
Robert A. Casillas ◽  
Lina Romero ◽  
Christian de Virgilio

1989 ◽  
Vol 80 (2) ◽  
pp. 274-278
Author(s):  
Akihiko Takamizawa ◽  
Junji Hirano ◽  
Manabu Ishigohka ◽  
Hiroyuki Watanabe ◽  
Shunzoh Kawamura

2008 ◽  
Vol 75 (4) ◽  
pp. 241-244 ◽  
Author(s):  
D. Zani ◽  
N. Arrighi ◽  
A. Antonelli ◽  
S. Cosciani Cunico ◽  
C. Simeone

The Renal Artery Aneurysm (RAA) is a relatively uncommon vascular lesion. A renal artery disease coexisting in patients with Renal Cell Carcinoma (RCC) is an even more infrequent clinical presentation. We reported on the treatment of a rare case of incidentally intraoperative renal artery aneurysm discovered during a nephron-sparing surgery for RCC. After the surgery the patient did not need hypertension therapy any longer. This event is well-known, in fact a number of possible contributions to a renin-mediated hypertension management has been postulated.


2015 ◽  
Vol 9 (6) ◽  
pp. 2356-2358
Author(s):  
ZIJIAN WANG ◽  
WEI XIONG ◽  
CIZHONG PAN ◽  
LIANG ZHU ◽  
PAN WANG ◽  
...  

1998 ◽  
Vol 30 (4) ◽  
pp. 385-390 ◽  
Author(s):  
O. Ichiyanagi ◽  
M. Ishigooka ◽  
Y. Suzuki ◽  
I. Sasagawa ◽  
T. Nakada ◽  
...  

1983 ◽  
Vol 38 (6) ◽  
pp. 374-377 ◽  
Author(s):  
Cesare Selli ◽  
Marco Carini ◽  
Damiano Turini ◽  
Aldo Schifano

2013 ◽  
Vol 137 (4) ◽  
pp. 467-480 ◽  
Author(s):  
Rajen Goyal ◽  
Elizabeth Gersbach ◽  
Ximing J. Yang ◽  
Stephen M. Rohan

Context.—The World Health Organization classification of renal tumors synthesizes morphologic, immunohistochemical, and molecular findings to define more than 40 tumor types. Of these, clear cell (conventional) renal cell carcinoma is the most common malignant tumor in adults and—with the exception of some rare tumors—the most deadly. The diagnosis of clear cell renal cell carcinoma on morphologic grounds alone is generally straightforward, but challenging cases are not infrequent. A misdiagnosis of clear cell renal cell carcinoma has clinical consequences, particularly in the current era of targeted therapies. Objective.—To highlight morphologic mimics of clear cell renal cell carcinoma and provide strategies to help differentiate clear cell renal cell carcinoma from other renal tumors and lesions. The role of the pathologist in guiding treatment for renal malignancies will be emphasized to stress the importance of proper tumor classification in patient management. Data Sources.—Published literature and personal experience. Conclusions.—In challenging cases, submission of additional tissue is often an inexpensive and effective way to facilitate a correct diagnosis. If immunohistochemical stains are to be used, it is best to use a panel of markers, as no one marker is specific for a given renal tumor subtype. Selection of limited markers, based on a specific differential diagnosis, can be as useful as a large panel in reaching a definitive diagnosis. For renal tumors, both the presence and absence of immunoreactivity and the pattern of labeling (membranous, cytoplasmic, diffuse, focal) are important when interpreting the results of immunohistochemical stains.


Sign in / Sign up

Export Citation Format

Share Document